Purpose
|
Dorsomorphin(Compound C, BML-275) has been shown to act as a potent and selective inhibitor of AMPK (AMP-activated protein kinase, Ki = 109 nM), induced by AICAR and metformin, also inhibits the bone morphogenetic protein type 1 receptors ACTR-I (ALK2), B
|